Order Article Reprints

De Corso E, Settimi S, Montuori C, Corbò M, Passali GC, Porru DP, Lo Verde S, Spanu C, Penazzi D, Di Bella GA, et al. Effectiveness of Dupilumab in the Treatment of Patients with Severe Uncontrolled CRSwNP: A “Real-Life” Observational Study in the First Year of Treatment. Journal of Clinical Medicine. 2022; 11(10):2684. https://doi.org/10.3390/jcm11102684

De Corso, Eugenio, Stefano Settimi, Claudio Montuori, Marco Corbò, Giulio Cesare Passali, Davide Paolo Porru, Simone Lo Verde, Camilla Spanu, Daniele Penazzi, Giuseppe Alberto Di Bella, and et al. 2022. "Effectiveness of Dupilumab in the Treatment of Patients with Severe Uncontrolled CRSwNP: A “Real-Life” Observational Study in the First Year of Treatment" Journal of Clinical Medicine 11, no. 10: 2684. https://doi.org/10.3390/jcm11102684

De Corso, E., Settimi, S., Montuori, C., Corbò, M., Passali, G. C., Porru, D. P., Lo Verde, S., Spanu, C., Penazzi, D., Di Bella, G. A., Nucera, E., Bonini, M., Paludetti, G., & Galli, J. (2022). Effectiveness of Dupilumab in the Treatment of Patients with Severe Uncontrolled CRSwNP: A “Real-Life” Observational Study in the First Year of Treatment. Journal of Clinical Medicine, 11(10), 2684. https://doi.org/10.3390/jcm11102684